AGM/EGMOct 26, 2026, 04:07 PM
Silexion Therapeutics Shareholders Approve Share Capital Increase and Reverse Split
AI Summary
Silexion Therapeutics Corp held an extraordinary general meeting where shareholders approved a significant increase in authorized share capital and a reverse stock split. The authorized share capital was increased by 500,000,000 ordinary shares, and a 1-for-24 reverse stock split was approved. Both proposals passed with strong majority support from the shareholders present.
Key Highlights
- Silexion Therapeutics Corp shareholders approved an increase in authorized share capital by 500,000,000 ordinary shares.
- Shareholders approved a reverse share split of 1-for-24, consolidating ordinary shares to a par value of $3.24.
- The authorized share capital increase was approved with 95.4% of votes in favor.
- The reverse share split proposal received 97.7% of votes in favor.
- Approximately 18.6% of the Company’s issued and outstanding ordinary shares were present at the meeting.
Price Impact
More from SLXN